First Participant Dosed in Study of BPL-003 Neurophysiological Effects
Investigators have dosed the first participant in a new study investigating the neurophysiological effects of BPL-003.
Source: psychiatrictimes.com
Page 3 - Rob Conley News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Rob Conley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Rob Conley Today - Breaking & Trending Today
The trial has started - can psychedelics help with alcohol addiction?
In an exciting collaboration, modern mental health company, Clerkenwell Health, and Beckley Psytech, a clinical-stage biotechnology company, have launched a phase 2a study aimed at investigating a potential breakthrough treatment for alcohol use disorder (AUD).
Source: outsourcing-pharma.com
NOVEL PSYCHEDELIC COMPOUND TO BE TESTED FOR TREATMENT OF ALCOHOL USE DISORDER
NOVEL PSYCHEDELIC COMPOUND TO BE TESTED FOR TREATMENT OF ALCOHOL USE DISORDER Novel psychedelic compound, combined with psychological support, will be explored as a potential new treatment for people living with alcohol use disorder (AUD).The trial uses Beckley Psytech’s lead candidate BPL-003, a short-du...
Source: pharmiweb.com
Negev Capital celebrates psychedelic medicine milestones across globe
Venture Capital firm, Negev Capital, holds a portfolio of companies creating neuropsychiatric drugs based on psychedelic molecules.
Source: outsourcing-pharma.com